SS INNOVATIONS INTERNATIONAL, INC. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
SS INNOVATIONS INTERNATIONAL, INC. (SSII) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $782.79 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-13
- SS INNOVATIONS INTERNATIONAL, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $526.35K, a 66.70% decline year-over-year.
- SS INNOVATIONS INTERNATIONAL, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was $256.44K, a 430.59% increase year-over-year.
- SS INNOVATIONS INTERNATIONAL, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $211.00K.
- SS INNOVATIONS INTERNATIONAL, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was -$1.68M, a 488.05% decline year-over-year.
- SS INNOVATIONS INTERNATIONAL, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $161.91K, a 85.85% decline from fiscal 2024.
- SS INNOVATIONS INTERNATIONAL, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was $1.14M.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $526.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $782.79K 10-Q · filed 2026-08-13 | $993.78K derived: sum of 3 quarters · filed 2026-08-13 | -$684.43K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $256.44K 10-Q · filed 2026-05-13 | $467.44K derived: sum of 2 quarters · filed 2026-05-13 | -$1.21M derived: sum of 3 quarters · filed 2026-05-13 | $370.02K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | $211.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$1.47M derived: sum of 2 quarters · filed 2026-03-10 | $113.58K derived: sum of 3 quarters · filed 2026-08-13 | $161.91K 10-K · filed 2026-03-10 | |
| 2025-09-30 | -$1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$97.41K derived: sum of 2 quarters · filed 2026-08-13 | -$49.08K 10-Q · filed 2025-10-28 | -$146.34K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.63M 10-Q · filed 2026-08-13 | $1.53M derived: sum of 3 quarters · filed 2026-08-13 | $1.96M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $48.33K 10-Q · filed 2026-05-13 | -$48.93K derived: sum of 2 quarters · filed 2026-05-13 | $383.55K derived: sum of 3 quarters · filed 2026-05-13 | $486.91K derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | -$97.26K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $335.22K derived: sum of 2 quarters · filed 2026-03-10 | $438.58K derived: sum of 3 quarters · filed 2026-03-10 | $1.14M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $432.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $535.84K derived: sum of 2 quarters · filed 2025-10-28 | $1.24M 10-Q · filed 2025-10-28 | $2.44M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $103.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $808.82K 10-Q · filed 2025-08-06 | |||
| 2024-03-31 | $705.46K 10-Q · filed 2025-05-14 | ||||
| 2023-09-30 | $52.87K 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| CARLSMED, INC. (CARL) | United States | $0.405B |